This site makes use of Javascript, please enable your web browser to allow Javascript. Thank you.
Julie B. du Pont

Julie B. du Pont

Counsel

纽约
T: (212) 836-8572
F: (212) 836-6418


icon 下载联系方式

执业领域

教育背景

  • Northwestern University School of Law
    J.D., cum laude, 2001
  • Brown University
    B.A., 1997; with honors

律师资格

  • New York, 2002
  • U.S. District Courts for the Southern, Eastern and Western Districts of New York

Julie du Pont is Counsel in Kaye Scholer’s New York office and a member of the firm’s Life Sciences group. Her practice focuses on pharmaceutical product liability litigation as well as complex commercial litigation and government investigations. Julie has extensive state and federal court experience representing major US and international corporations and individual clients in all phases of the litigation process, including motion practice, discovery, trial preparation and trial, and settlement.

Julie has substantial experience representing pharmaceutical companies, including Pfizer, Novartis, Boston Scientific and AstraZeneca, in product liability lawsuits involving both prescription drugs and medical devices. Julie has been a key member of national coordinating counsel teams and trial teams. A focus of her practice is developing and rebutting expert medical and scientific evidence, and litigating the admissibility of expert opinion testimony.

Julie is committed to the firm's pro bono program and has worked with clients on a variety of matters, including orders of protection, divorce and social security benefits.

She is a member of the New York City Bar’s Product Liability Committee.

Publications and Presentations

  • Credited Contributor, “The Restatement Sections Specifically Applicable to Pharmaceutical and Medical Device Cases in State Court: A 50-State Survey,” American Bar Association, 2004.

  • ABA Panel Member, “The Increasing Attempts to Use U.S. Courts by Foreign Plaintiffs,” Pharmaceutical Regional CLE Workshop: Current Issues in Pharmaceutical Law and Policy, 2006.